Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Conditions
Interventions
Intervention1: Low dose intravenous ketamine: Five minutes after delivery, women in the experimental group will be given 0.25 mg/kg intravenous ketamine via bolus dose
Control Intervention1: Normal sa
Sponsors
Dr Chethana M
Eligibility
Inclusion criteria
Inclusion criteria: ASA I to II Patients Female patients. Aged between 20 to 40years. Normal liver and renal function test, Coagulation profile. Undergoing Lower Segment Caesarean Section Surgery.
Exclusion criteria
Exclusion criteria: Patients with history of allergy to local Anaesthetics. Patients with history of mental disorders. Patient Refusal. Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders. Patients with hypertensive disorder due to any cause ( PIH)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of post operative pain relief with single dose of intravenous ketamine during cesarean sectionTimepoint: A visual analogue score will be used to record the participants pain score at 1, 2, 6, 12 hours following surgery. Participants will be asked to rate the intensity of their pain in the scale of one (no pain at all) to 10 (very intense and unimaginable pain). | — |
Secondary
| Measure | Time frame |
|---|---|
| First rescue analgesia used. Total analgesic consumed in first 24hrs Hemodynamic parameters for 24 hours post operatively. Adverse effects, if any. Timepoint: Participants will be monitored for common side effects, such as nausea, vomiting, headache, hallucination, and itching, and the prevalence of such side effects will be recorded at 1,2,6 and 12 hrs following surgery. | — |
Countries
India
Contacts
Public ContactDr S Rangalakshmi
Rajarajeswari medical college and hospital
Outcome results
None listed